Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. Co. operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. We show 61 historical shares outstanding datapoints in our INCY shares outstanding history coverage, used to compute INCY market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing INCY market cap history over the course of time is important for investors
interested in comparing INCY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of INCY versus a peer is one thing; comparing
INCY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like INCY can fluctuate over the course of history.
With this page we aim to empower investors researching INCY by allowing them to research the INCY market cap history. |
Free INCY Email Alerts:
Video: The Importance of Market Cap
